Literature DB >> 10899889

Nonimmune interaction of the SfbI protein of Streptococcus pyogenes with the immunoglobulin G F(ab')(2) fragment.

E Medina1, K Schulze, G S Chhatwal, C A Guzmán.   

Abstract

Fibronectin-binding protein I (SfbI) of Streptococcus pyogenes binds to mouse immunoglobulin G (IgG) but not to IgA or IgM in a nonimmune fashion. The fibronectin-binding domains of SfbI were responsible for this activity, which was targeted to the IgG F(ab')(2) fragment. SfbI also binds to B cells but not to CD4(+) or CD8(+) lymphocytes.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10899889      PMCID： PMC98438          DOI： 10.1128/IAI.68.8.4786-4788.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  14 in total

1.  Fc-mediated nonspecific binding between fibronectin-binding protein I of Streptococcus pyogenes and human immunoglobulins.

Authors:  E Medina; G Molinari; M Rohde; B Haase; G S Chhatwal; C A Guzmán
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

2.  Evidence for functional heterogeneity in IgG Fc-binding proteins associated with group A streptococci.

Authors:  R Raeder; E L Faulmann; M D Boyle
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

3.  A surface component in group A, C, and G streptococci with non-immune reactivity for immunoglobulin G.

Authors:  G Kronvall
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

4.  Streptococcal protein G has affinity for both Fab- and Fc-fragments of human IgG.

Authors:  M Erntell; E B Myhre; U Sjöbring; L Björck
Journal:  Mol Immunol       Date:  1988-02       Impact factor: 4.407

5.  Fc gamma-like determinants on immunoglobulin variable regions: identification by staphylococcal protein A.

Authors:  S Biguzzi
Journal:  Scand J Immunol       Date:  1982-06       Impact factor: 3.487

6.  Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus.

Authors:  K J Reis; E M Ayoub; M D Boyle
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

7.  Comparison of mechanisms of interaction between protein A from Staphylococcus aureus and human monoclonal IgG, IgA and IgM in relation to the classical FC gamma and the alternative F(ab')2 epsilon protein A interactions.

Authors:  M Inganäs
Journal:  Scand J Immunol       Date:  1981       Impact factor: 3.487

8.  Non-immune F(ab')2- and Fc-mediated interactions of mammalian immunoglobulins with S. aureus and group C and G streptococci.

Authors:  M Erntell; E B Myhre; G Kronvall
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1986-12

9.  Polyclonal activation of human lymphocytes in vitro. I. Characterization of the lymphocyte response to a T cell-independent B cell mitogen.

Authors:  R K Schuurman; E W Gelfand; H M Dosch
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

10.  Alternative non-immune F(ab')2-mediated immunoglobulin binding to group C and G streptococci.

Authors:  M Erntell; E B Myhre; G Kronvall
Journal:  Scand J Immunol       Date:  1983-03       Impact factor: 3.487
View more
  3 in total

1.  Identification of Plasmodium falciparum var1CSA and var2CSA domains that bind IgM natural antibodies.

Authors:  Jean-Philippe Semblat; Ahmed Raza; Sue A Kyes; J Alexandra Rowe
Journal:  Mol Biochem Parasitol       Date:  2006-01-06       Impact factor: 1.759

Review 2.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

3.  Virulence Role of the GlcNAc Side Chain of the Lancefield Cell Wall Carbohydrate Antigen in Non-M1-Serotype Group A Streptococcus.

Authors:  Anna Henningham; Mark R Davies; Satoshi Uchiyama; Nina M van Sorge; Sean Lund; Kelsey T Chen; Mark J Walker; Jason N Cole; Victor Nizet
Journal:  mBio       Date:  2018-01-30       Impact factor: 7.867
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.